Archer Investment Corporation’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-365
Closed -$61.8K 889
2022
Q4
$61.8K Hold
365
0.02% 325
2022
Q3
$68.3K Hold
365
0.03% 289
2022
Q2
$59.3K Hold
365
0.02% 311
2022
Q1
$68.7K Buy
+365
New +$69.3K 0.02% 312

Other funds holding RGEN

Archer Investment Corporation's RGEN Position: Q1 2023 in Review

Archer Investment Corporation sold out of Repligen (RGEN) in Q1 2023, closing a stake of 365 shares — an estimated $61.8K sold.

Archer Investment Corporation first reported a position in RGEN in Q1 2022 and held it in 4 quarters. The position peaked at $68.7K in Q1 2022. 447 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

  • Archer Investment Corporation reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
  • Archer Investment Corporation sold 365 Repligen shares in Q1 2023, an estimated $61.8K.
  • Archer Investment Corporation first reported a position in Repligen in Q1 2022 and held it in 4 quarters.
  • Archer Investment Corporation's Repligen position peaked at $68.7K in Q1 2022.
  • 447 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on Archer Investment Corporation's 13F filing for Q1 2023, filed 9 May 2023.